'Gaucher disease' presentation slideshows

Skin: Neurofibromatosis

Skin: Neurofibromatosis. Lab 5, Case 1. Neurofibromas Some lesions can be seen as subcutaneous swellings (arrow) and others form pedunculated masses. Most are hyperpigmented. Subcutaneous neurofibroma (1) Note the increased pigmentation in the skin (2).

1.12k views • 77 slides

CURRENT AND FUTURE STRATEGIES FOR THE TREATMENT OF METABOLIC STORAGE DISORDERS

CURRENT AND FUTURE STRATEGIES FOR THE TREATMENT OF METABOLIC STORAGE DISORDERS 1. BONE MARROW TRANSPLANTATION 2. ENZYME REPLACEMENT THERAPY 3. SUBSTRATE REDUCTION THERAPY 4. MOLECULAR CHAPERONE THERAPY 5. GENE THERAPY.

764 views • 63 slides

Genetic Disorders

780 views • 50 slides

Genetic Disorders

748 views • 50 slides

Petsko/Ringe Lab Research

507 views • 38 slides

Genetic and Pediatric Diseases

Genetic and Pediatric Diseases. Chapter 6. ???? ???. ???? ?????. Diseases Caused by Mutations in Genes Encoding Structural Proteins. Marfan Syndrome Ehlers-Danlos Syndromes. ????? ??????? ???? ? ????? ?? ???? ?????? ????.

415 views • 37 slides

Gaucher Disease: Bone Imaging

Gaucher Disease: Bone Imaging. DXA (Dual-Energy X-ray Absorptiometry). DXA Spine Image and Test Results. DXA Hip Image and Test Results. Absorptiometry. DXA: Trabecular Bone Change. BMD ?. BMD ?. BMD ?. DXA: Cortical Bone Change. BMD ?. BMD ?. BMD ?. Computed Tomography.

477 views • 17 slides

Agenda

241 views • 14 slides

Gaucher Disease: a case report

Gaucher Disease: a case report. Sarro Rossella, Laurence de Leval Institute of Pathology University Hospital, CHUV, CH-Lausanne. HE. HE. HE. HE. HE. PAS. CD68/PGM1. CD68/PGM1. CD68/PGM1. FVIII.

207 views • 11 slides

Global Gaucher Disease By Application | Non-neuronopathic Gaucher disease Forecast to 2022

Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.

212 views • 9 slides

Global Gaucher Disease Market 2015-2019

Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities. Get detailed information on: http://www.researchbeam.com/global-gaucher-disease-2015-2019-market

272 views • 5 slides

Gaucher Disease Market Challenges, Key players and Market growth by 2021

Gaucher Disease Market Includes in-depth analysis of Market Application, Size, Specification, Trends, Major Manufacturers and Business Strategies by Considering Types, Market Segmentation and Analysis.

110 views • 5 slides

Gaucher Disease Drugs Market Global Industry Size, Manufacturers, Share, Types, End User and Future Forecast 2018

This report studies Gaucher Disease Drugs market, especially in North America, China, Europe, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions.

103 views • 5 slides

Gaucher Disease Market Analysis by Types, Applications and Manufacturers till 2025

51 views • 4 slides